Journal of Cardiac Failure
Volume 15, Issue 10 , Pages 835-842 , December 2009

Relationship of Quality of Life Scores With Baseline Characteristics and Outcomes in the African-American Heart Failure Trial

  • Peter Carson, MD

      Affiliations

    • Veterans Affairs Medical Center, Washington, DC
    • Corresponding Author InformationReprint requests: Peter Carson, MD, Veterans Affairs Medical Center, 50 Irving Street NW, Washington, DC 20422-0001. Tel: (202) 745-8109; Fax: (202) 745-8172.
    • ,
  • S. William Tam, PhD

      Affiliations

    • NitroMed, Inc., Lexington, MA
    • ,
  • Jalal K. Ghali, MD

      Affiliations

    • Wayne State University, Detroit, MI
    • ,
  • W. Tad Archambault, PhD

      Affiliations

    • Virtu Stat, Ltd, North Wales, PA
    • ,
  • Anne Taylor, MD, FACC

      Affiliations

    • Columbia University Medical Center, New York, NY
    • ,
  • Jay N. Cohn, MD, FACC

      Affiliations

    • University of Minnesota, Minneapolis, MN
    • ,
  • Virginia M. Braman

      Affiliations

    • NitroMed, Inc., Lexington, MA
    • ,
  • Manuel Worcel, MD

      Affiliations

    • NitroMed, Inc., Lexington, MA
    • ,
  • Inder S. Anand, MD, FACC, FRCP, DPHIL (OXON.)

      Affiliations

    • University of Minnesota, Minneapolis, MN
    • Veterans Affairs Medical Center, Minneapolis, MN

Received 6 January 2009 ,Revised 28 May 2009 ,Accepted 29 May 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 All decisions for this manuscript were made by a guest editor.

 A-HeFT was funded by NitroMed, Inc, Lexington, MA. Authors are either consultants of NitroMed, Inc. (A.N.T., I.S.A., J.K.G., J.N.C., P.C., W.T.A.) or are/were employees of NitroMed (V.B., M.W., S.W.T.). Dr. Cohn has a royalty relationship with NitroMed based on his patents of the drug combination.

 Dr. Braman was an employee of NitroMed, Inc. from 2001-2008.

 Dr. Taylor has received research support and honoraria from NitroMed, Inc.

 Dr. Archambault served as a consultant to NitroMed, Inc.

 A-HeFT = African-American Heart Failure Trial BEST = Beta-Blocker Evaluation of Survival Trial CHARM = Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity.

PII: S1071-9164(09)00192-4

doi: 10.1016/j.cardfail.2009.05.016

Journal of Cardiac Failure
Volume 15, Issue 10 , Pages 835-842 , December 2009

Article Tools

* Image Usage & Resolution